Dexcom Inc (DXCM)

May 13, 2025, 8:30 AM EDT - 19 days ago

Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO

May 9, 2025, 11:00 AM EDT - 22 days ago

DexCom Q1 Earnings: Organic Revenue Growth Versus Cost Pressure

May 5, 2025, 4:34 AM EDT - 27 days ago

DexCom: Growth Is Reaccelerating But Don't Ignore The Risks

May 2, 2025, 1:43 PM EDT - 4 weeks ago

Nasdaq Index: Dexcom, Meta, ON Semi Lead US Stocks Rebound on Trade Optimism

META ON

May 2, 2025, 11:53 AM EDT - 4 weeks ago

Dexcom Stock Is Today's Big Winner After Earnings. Why the Medtech Is Soaring.

May 1, 2025, 9:04 PM EDT - 4 weeks ago

DexCom, Inc. (DXCM) Q1 2025 Earnings Call Transcript

May 1, 2025, 4:54 PM EDT - 4 weeks ago

Dexcom beats quarterly sales estimates, reiterates annual forecast

May 1, 2025, 4:02 PM EDT - 4 weeks ago

Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program

Apr 30, 2025, 4:12 PM EDT - 4 weeks ago

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump's pharma tariffs loom

ABBV ABT GSK JNJ LLY MRK NVS

Apr 16, 2025, 12:51 PM EDT - 6 weeks ago

Healthy Returns: What drugmakers are saying about Trump's looming pharmaceutical tariffs

JNJ LLY

Apr 10, 2025, 1:28 PM EDT - 7 weeks ago

FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch

Apr 10, 2025, 11:34 AM EDT - 7 weeks ago

DexCom Stock Rises as Glucose Monitoring System Gets FDA Clearance

Apr 10, 2025, 8:30 AM EDT - 7 weeks ago

Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System

Apr 3, 2025, 8:30 AM EDT - 2 months ago

Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time.

Apr 1, 2025, 8:00 AM EDT - 2 months ago

Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems

Mar 31, 2025, 5:02 PM EDT - 2 months ago

These 20 worst-performing stocks in the S&P 500 sank 17% or more in March

DAL BBY CCL CEG CZR DECK EPAM

Mar 25, 2025, 4:05 PM EDT - 2 months ago

Dexcom Appoints Jon Coleman as Chief Commercial Officer

Mar 25, 2025, 11:50 AM EDT - 2 months ago

Nanowear Announces Continuous Glucose Monitoring (CGM) Licensing and Data Partnership With Dexcom

Mar 19, 2025, 4:00 AM EDT - 2 months ago

Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care

Mar 14, 2025, 7:00 AM EDT - 2 months ago

History Says Shut Up And Buy: 12 Hyper-Growth Blue Chips To Buy Right Now

AMZN ASML BAM CGNX KFRC LCII MAN

Mar 10, 2025, 8:30 AM EDT - 2 months ago

Dexcom Appoints Renée Galá to Board of Directors

Mar 7, 2025, 5:52 PM EST - 3 months ago

Dexcom receives FDA warning letter for two U.S. manufacturing facilities

Mar 7, 2025, 5:33 PM EST - 3 months ago

DexCom Gets FDA Warning Letter After Inspections of Facilities

Mar 4, 2025, 1:13 PM EST - 3 months ago

DexCom, Inc. (DXCM) Presents at 46th Annual Raymond James Institutional Investors Brokers Conference (Transcript)

Feb 27, 2025, 8:30 AM EST - 3 months ago

Dexcom Announces Upcoming Conference Presentation

Feb 21, 2025, 3:48 PM EST - 3 months ago

Quality Key in Volatile Market, NFLX & DXCM Value Plays

NFLX

Feb 14, 2025, 3:04 PM EST - 3 months ago

Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom

Feb 14, 2025, 9:22 AM EST - 3 months ago

DexCom Analysts Increase Their Forecasts After Q4 Earnings

Feb 13, 2025, 9:33 PM EST - 3 months ago

DexCom, Inc. (DXCM) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 5:09 PM EST - 3 months ago

Dexcom beats fourth-quarter sales, reiterates 2025 revenue forecast

Feb 13, 2025, 4:02 PM EST - 3 months ago

Dexcom Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Jan 30, 2025, 8:30 AM EST - 4 months ago

Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time.

Jan 17, 2025, 4:43 PM EST - 4 months ago

DexCom: Fairly Priced In 2025; Why I'm Not Expecting A Share Price Comeback

Jan 14, 2025, 4:31 PM EST - 4 months ago

Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals

AMZN LLY GSK JNJ MRNA NVDA TDOC

Jan 13, 2025, 7:43 AM EST - 4 months ago

Dexcom forecasts 2025 revenue mostly in-line with expectations

Jan 13, 2025, 7:30 AM EST - 4 months ago

Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook

Jan 7, 2025, 8:30 AM EST - 5 months ago

Dexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference

Dec 24, 2024, 8:00 AM EST - 5 months ago

Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown

DOCS GDRX HIMS OSCR PGNY TDOC TEM

Dec 23, 2024, 4:56 PM EST - 5 months ago

DexCom, Abbott Agree to Settlement in Patent Litigation

ABT

Dec 23, 2024, 4:17 PM EST - 5 months ago

Abbott and DexCom settle glucose monitor patent disputes

ABT

Dec 19, 2024, 8:30 AM EST - 5 months ago

Diabetes Brands Dexcom, Ozempic, Mounjaro Drive Q3 Convergent TV Ad Engagement

Dec 17, 2024, 9:00 AM EST - 5 months ago

Dexcom's over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levels

Dec 17, 2024, 9:00 AM EST - 5 months ago

Dexcom Launches the First Generative AI Platform in Glucose Biosensing

Dec 17, 2024, 8:00 AM EST - 5 months ago

Alberta Government Lifts Age Restrictions on Continuous Glucose Monitors (CGM) and Eligible Albertans With Type 1 or Type 2 Diabetes Can Now Access Dexcom G7 CGM

Dec 10, 2024, 3:18 PM EST - 6 months ago

DexCom: Brighter 2025 From Stelo Ramp

Dec 5, 2024, 7:00 AM EST - 6 months ago

11 Ultra SWAN Bargains That Could Thrive As The Market Soars To Record Highs

ADBE AMZN BXP CMCSA GPN ILMN PFE

Nov 19, 2024, 12:50 PM EST - 6 months ago

DexCom Pairs Its Glucose Monitor With Oura's Smart Ring

Nov 19, 2024, 7:47 AM EST - 6 months ago

Oura CEO on new partnership with Dexcom

Nov 19, 2024, 6:15 AM EST - 6 months ago

Smart ring maker Ōura valued at over $5 bln after Dexcom funding